Rossari Biotech Limited
Rossari Biotech Limited manufactures and sells specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; performance additives; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, printi… Read more
Rossari Biotech Limited (ROSSARI) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2023: 0.031x
Based on the latest financial reports, Rossari Biotech Limited (ROSSARI) has a cash flow conversion efficiency ratio of 0.031x as of September 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹302.28 Million) by net assets (₹9.78 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Rossari Biotech Limited - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Rossari Biotech Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Rossari Biotech Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Rossari Biotech Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Gotland Rederi AB Series B
ST:GOTL-B
|
0.031x |
|
Celtic plc
PINK:CLTFF
|
-0.038x |
|
KlaraBo Sverige AB Series B
ST:KLARA-B
|
0.010x |
|
EVA Precision Industrial Holdings Limited
F:GZT
|
0.015x |
|
Ubiquoss Inc
KQ:264450
|
0.071x |
|
Kejuruteraan Asastera Bhd
KLSE:0193
|
-0.273x |
|
Summit Bank Group Inc
PINK:SBKO
|
N/A |
|
Sea1 Offshore Inc.
OL:SEA1
|
0.088x |
Annual Cash Flow Conversion Efficiency for Rossari Biotech Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Rossari Biotech Limited from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹11.85 Billion | ₹1.37 Billion | 0.116x | +180.84% |
| 2024-03-31 | ₹10.48 Billion | ₹432.55 Million | 0.041x | -75.21% |
| 2023-03-31 | ₹9.15 Billion | ₹1.52 Billion | 0.167x | +356.69% |
| 2022-03-31 | ₹8.05 Billion | ₹293.58 Million | 0.036x | -68.80% |
| 2021-03-31 | ₹4.09 Billion | ₹477.67 Million | 0.117x | -38.90% |
| 2020-03-31 | ₹2.87 Billion | ₹548.28 Million | 0.191x | -66.73% |
| 2019-03-31 | ₹1.24 Billion | ₹711.77 Million | 0.575x | +95.79% |
| 2018-03-31 | ₹870.80 Million | ₹255.69 Million | 0.294x | +287.66% |
| 2017-03-31 | ₹619.85 Million | ₹46.95 Million | 0.076x | -- |